Comment on

• Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial.

  Boaz M, Smetana S, Weinstein T, Matas Z, Gafter U, Iaina A, Knecht A, Weissgarten Y, Brunner D, Fainaru M, Green MS. Boaz M, et al. Lancet. 2000 Oct 7;356(9237):1213-8. doi: 10.1016/s0140-6736(00)02783-5. Lancet. 2000. PMID: 11072938 Clinical Trial.
• Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project.

  de Gaetano G; Collaborative Group of the Primary Prevention Project. de Gaetano G, et al. Lancet. 2001 Jan 13;357(9250):89-95. doi: 10.1016/s0140-6736(00)03539-x. Lancet. 2001. PMID: 11197445 Clinical Trial.